Infliximab against severe COVID-19-induced cytokine storm syndrome with organ failure—a cautionary case series
Infliximab against severe COVID-19-induced cytokine storm syndrome with organ failure—a cautionary case series is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Infliximab against severe COVID-19-induced cytokine storm syndrome with organ failure—a cautionary case series have?
Infliximab against severe COVID-19-induced cytokine storm syndrome with organ failure—a cautionary case series has 91 citations in the OpenAlex counts ScholarIQ stores.
When was Infliximab against severe COVID-19-induced cytokine storm syndrome with organ failure—a cautionary case series published?
Infliximab against severe COVID-19-induced cytokine storm syndrome with organ failure—a cautionary case series has 2020 year in the ScholarIQ index.
What is the open-access status of Infliximab against severe COVID-19-induced cytokine storm syndrome with organ failure—a cautionary case series?
Infliximab against severe COVID-19-induced cytokine storm syndrome with organ failure—a cautionary case series has gold oa status in the ScholarIQ index.
What is the DOI of Infliximab against severe COVID-19-induced cytokine storm syndrome with organ failure—a cautionary case series?
The DOI for Infliximab against severe COVID-19-induced cytokine storm syndrome with organ failure—a cautionary case series is on the source record.
What is the PMID of Infliximab against severe COVID-19-induced cytokine storm syndrome with organ failure—a cautionary case series?
The PMID for Infliximab against severe COVID-19-induced cytokine storm syndrome with organ failure—a cautionary case series is on the source record.
What is the OpenAlex record for Infliximab against severe COVID-19-induced cytokine storm syndrome with organ failure—a cautionary case series?
The OpenAlex for Infliximab against severe COVID-19-induced cytokine storm syndrome with organ failure—a cautionary case series is on the source record.